News
-
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
August 25, 2023 -
Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
June 14, 2023 -
Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting
June 8, 2023 -
Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
May 30, 2023 -
Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD
May 23, 2023 -
Aclarion, Inc. Announces Delayed 10-Q Filing
May 23, 2023 -
Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts
May 19, 2023 -
Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain
May 2, 2023 -
Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023
April 28, 2023 -
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
April 24, 2023